Abstract | PURPOSE OF REVIEW: An increasing number of reports indicate that low levels of the endogenous amino acid L- homoarginine are linked to cardiovascular disease. In this article, we review the current findings regarding L- homoarginine metabolism and (patho-)physiology with a focus on its clinical impact. RECENT FINDINGS: Recent clinical and epidemiological studies revealed a strong association of low circulating L- homoarginine with cardiovascular outcomes and mortality. Human and murine studies identified L-arginine:glycine amidinotransferase (AGAT) as the responsible enzyme for endogenous L- homoarginine formation, suggesting a further important function of AGAT apart from its involvement in creatine and energy metabolism. Further studies related L- homoarginine to smoking and hypertension, and metabolic phenotypes. SUMMARY:
|
Authors | Dorothee Atzler, Edzard Schwedhelm, Chi-un Choe |
Journal | Current opinion in clinical nutrition and metabolic care
(Curr Opin Clin Nutr Metab Care)
Vol. 18
Issue 1
Pg. 83-8
(Jan 2015)
ISSN: 1473-6519 [Electronic] England |
PMID | 25474016
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Homoarginine
- Amidinotransferases
|
Topics |
- Amidinotransferases
(deficiency)
- Amino Acid Metabolism, Inborn Errors
(complications)
- Animals
- Cardiovascular Diseases
(etiology, metabolism)
- Developmental Disabilities
(complications)
- Energy Metabolism
- Homoarginine
(deficiency, metabolism)
- Humans
- Intellectual Disability
(complications)
- Speech Disorders
(complications)
|